1 Department of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
2 Department of Biochemistry, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
3 Department of Pediatrics, Benha Educational Hospital, Benha, Egypt.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Childhood acute lymphoblastic leukemia (ALL) with current cure rates
reaching 80% emphasizes the necessity to determine treatment-related
long-term effects. The aim of this study is to estimate the prevalence
of overweight, obesity, and hepatic late adverse effects in a cohort of
ALL survivors treated at the Hematology and Oncology Unit, Pediatrics
Department, Menoufia University, Egypt.
Patients and Methods
|Table 1. Z-score of anthropometric measures of studied groups|
|Table 2. Multivariate analysis of predicting risk factors for obesity.|
|Table 3. Laboratory investigations of studied groups.|
|Table 4. HCV Antibodies in studied groups.|
|Table 5. Correlation between risk of liver abnormalities in patients and higher asparaginase cumulative dosage.|
|Table 6. Correlation between liver abnormalities and increased ferritin level.|